GH Capital’s Vitana-X Closes Acquisition of its Licensee in Europe
Vitana-X Europe Revenue to be Included in Next Earnings Report in February 2021
MIAMI, FL / ACCESSWIRE / December 21, 2020 / GH Capital, Inc. (OTC PINK: GHHC ), through its Vitana-X subsidiary, a provider of comprehensive programs for greater well-being, fitness and health with a wellness network marketing program, is pleased to announce that it has closed its acquisition of Vitana-X Europe AG., a Swiss-based sales and marketing firm with an estimated revenue of $2.5 million in 2020. GHHC now owns 100% of the outstanding shares of Vitana X AG Switzerland.
Vitana-X Europe’s revenue will be included when GHHC next reports its quarterly results, which is due by February 28, 2021.
In regards to the Company’s OTC Markets listing, the company had to re-apply to register in order to be able to publish its quarterly and annual reports as an Alternative OTC reporting company. The application has been submitted and will be processed by OTC Markets. As soon it has been completed the annual report will be immediately published.
In regards to FINRA, the company is still waiting for its name change and new trading symbol.
About GH Capital / Vitana-X
GH Capital, Inc.’s (OTC: GHHC ) Vitana-X, an international wellness company specializing in the development and manufacture of health-promoting products based on DNA analysis. As a pioneer in this industry and a worldwide network of highly qualified experts, it offers its customers extensive opportunities to lead a healthier life. Vitana-X offers comprehensive programs for greater well-being, fitness and health by helping you achieve the desired results and offering exercises that fit your body type. Vitana-X wants to support people in their healthy development and be their reliable partner for their full potential. Vitana-X comes from two worlds and wants to unite them in the future - science and the challenges of daily life, so that its customers can continue to care for other areas of life without sacrificing a healthy life.
For additional information on Vitana-X, please visit: https://vitanax.net/en/.
Forward-Looking Statements. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Form 10-K filed on December 28, 2019, for the fiscal year ended September 30, 2018, including but not limited to the discussion under “Risk Factors” therein, which the Company has filed with the SEC and which may be viewed at http://www.sec.gov.
SOURCE: GH Capital, Inc.
View source version on accesswire.com: